PPD

PPD

As one of the leading global contract research organizations (CROs), PPD delivers a comprehensive range of Phase I, Phase II-IIIb and post-approval services. Our expertise spans a breadth of therapeutic areas including oncology, infectious diseases, cardiovascular, endocrinology and metabolic studies, and central nervous system, closely aligning with industry’s top research and development priorities.

We have a 300-bed healthy volunteer Phase I clinic and dental pain research clinic in Austin, Texas, which is able to accommodate large clinical trials. To help our clients efficiently manage multinational trials under multiple regulatory requirements, we deliver a continuum of Phase II-IIIb services that include clinical development, program management, monitoring, biostatistics, data management, regulatory management and pharmacovigilance. In addition, we understand our clients’ increasing concerns to ensure the safety of marketed drugs, and we bring strong post-approval expertise in late stage research, including epidemiology, risk management, REMS, safety surveillance studies, observational studies and pregnancy registries, and medical communications.

Demand for our global services continues to increase due to our scientific expertise, innovative technologies and operational excellence. In 2009, we managed 987 global regional and country-specific Phase II-IV studies, including 568 clinical protocols involving more than 323,700 patients at more than 36,200 sites.